Nsp2 has the potential to be a drug target revealed by global identification of SARS-CoV-2 Nsp2-interacting proteins. (23rd June 2021)

• Record Type: Journal Article
• Authors: Zheng, Yun-Xiao; Wang, Lei; Kong, Wei-Sha; Chen, Hong; Wang, Xue-Ning; Meng, Qingfeng; Zhang, Hai-Nan; Guo, Shu-Juan; Jiang, He-Wei; Tao, Sheng-Ce
• Is Part Of: Acta biochimica et biophysica Sinica. Volume 53:Number 9(2021)
• Page Start: 1134
• Page End: 1141
• Publication Date: 2021-06-23
• Subjects: Nsp2 -- SARS-CoV-2 -- protein–protein interaction -- AP-MS -- SILAC; Biochemistry -- Periodicals; Biophysics -- Periodicals; 572.05
• DOI: 10.1093/abbs/gmab088
• Languages: English
• ISSNs: 1672-9145

Abstract

Abstract: Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) has become a global health threat since December 2019, and there is still no highly effective drug to control the pandemic. To facilitate drug target identification for drug development, studies on molecular mechanisms, such as SARS-CoV-2 protein interactions, are urgently needed. In this study, we focused on Nsp2, a non-structural protein with largely unknown function and mechanism. The interactome of Nsp2 was revealed through the combination of affinity purification mass spectrometry (AP-MS) and stable isotope labeling by amino acids in cell culture (SILAC), and 84 proteins of high-confidence were identified. Gene ontology analysis demonstrated that Nsp2-interacting proteins are involved in several biological processes such as endosome transport and translation. Network analysis generated two clusters, including ribosome assembly and vesicular transport. Bio-layer interferometry (BLI) assay confirmed the bindings between Nsp2- and 4-interacting proteins, i.e. STAU2 (Staufen2), HNRNPLL, ATP6V1B2, and RAP1GDS1 (SmgGDS), which were randomly selected from the list of 84 proteins. Our findings provide insights into the Nsp2–host interplay and indicate that Nsp2 may play important roles in SARS-CoV-2 infection and serve as a potential drug target for anti-SARS-CoV-2 drug development.